The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026
These Regulations are made in exercise of the powers in sections 14(2), (3), (4)(a), (b), (c) and (e) and (7) and 20(1)(a) of the Retained EU Law (Revocation and Reform) Act 2023 (c. 28) (“the 2023 Act”). These Regulations revoke, replace and make alternative provision in secondary assimilated law which establish the processes and rules governing the control and trade in drug precursor chemicals in Great Britain, and trade between Great Britain, Northern Ireland and third countries.
Lifecycle
Department
Made
08 Jun 2026
—
Comes into force
29 Jun 2026
Enabling power
the 2023 Act The Secretary of State makes these Regulations in exercise of the powers conferred by sections 14(2), (3), (4)(a), (b), (c) and (e) and (7) and 20(1)(a) of the Retained EU Law (Revocation and Reform) Act 2023(“”). The Secretary of State is a relevant national authority for the purposes of section 14(2) and (3) of the 2023 Act. In accordance with paragraph 5(1) of Schedule 5 to the 2023 Act, a draft of this instrument has been laid before Parliament and approved by a resolution of each House of Parliament.
DocumentsOpen on legislation.gov.uk →